(Q44229450)

1 December 2017

DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients (English)

1 reference

invasive ductal carcinoma

1 December 2017

multivariate statistics

1 reference

based on heuristic

inferred from title

1 reference

António E Pinto

1

1 reference

1 December 2017

Teresa Pereira

2

1 reference

1 December 2017

Márcia Santos

3

1 reference

1 December 2017

Mariana Branco

4

1 reference

1 December 2017

Angelo Dias

5

1 reference

1 December 2017

Giovani L Silva

6

1 reference

1 December 2017

Mónica C Ferreira

7

1 reference

1 December 2017

Saudade André

8

1 reference

1 December 2017

20 December 2012

1 reference

Annals of Surgical Oncology

1 December 2017

1 reference

1 December 2017

20

1 reference

1 December 2017

1530-1537

1 reference

1 December 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-012-2804-6

1 December 2017

0 references

cites work

Current and emerging biomarkers in breast cancer: prognosis and prediction

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Overall Survival in Advanced Breast Cancer: Relevance of Progesterone Receptor Expression and DNA Ploidy in Fine-Needle Aspirates of 392 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Proliferative activity in primary breast carcinomas is a salient prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Consensus report of the task force on standardisation of DNA flow cytometry in clinical pathology. DNA Flow Cytometry Task Force of the European Society for Analytical Cellular Pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Mathematical analysis of DNA distributions derived from flow microfluorometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Traditional and new prognosticators in breast cancer: Nottingham index, Mib-1 and estrogen receptor signaling remain the best predictors of relapse and survival in a series of 289 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Breast cancer in very young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2804-6

10.1245/S10434-012-2804-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 December 2017

0 references

1 reference